#15133-2 – Adults with Varying Degrees of Hepatic Impairment

Location: Denver

Stay: 3 nights/4 days and 1 follow-up phone call

Gender: Male/Female

Ages: 18-75

Compensation: $1053

Smokers Allowed: Yes

Study Overview:

This study will be testing a new investigational study drug. We will be investigating the safety and tolerability of this study drug in individuals with liver disease to see if the drug passes through their body system any differently than in individuals with normal liver function, and to recommend a dose adjustment, if necessary.

Enroll In This Study